The molecular perspective: tumor necrosis factor.
Goodsell
David S
DS
The Scripps Research Institute, Department of Molecular Biology, La Jolla, California 92037, USA. goodsell@scripps.edu
D000970:Antineoplastic Agents / Q000737:chemistry / Q000627:therapeutic use; D051017:Apoptosis Regulatory Proteins / Q000737:chemistry / Q000627:therapeutic use; D006801:Humans; D008562:Membrane Glycoproteins / Q000737:chemistry / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology*; D015398:Signal Transduction / Q000276:immunology; D053221:TNF-Related Apoptosis-Inducing Ligand; D014409:Tumor Necrosis Factor-alpha / Q000737:chemistry / Q000276:immunology* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D051017:Apoptosis Regulatory Proteins; D008562:Membrane Glycoproteins; D053221:TNF-Related Apoptosis-Inducing Ligand; C505653:TNFSF10 protein, human; D014409:Tumor Necrosis Factor-alpha